Clinical trial data provides hope for attenuation of mucosal injury in coeliac disease

European Journal of Internal Medicine

Volumn 23, Issue 3, 2012, Pages

  Pérez, Laura Crespo ^a   León, Francisco ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b CENTOCOR INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTEN;

CELIAC DISEASE; ENTERITIS; GLUTEN FREE DIET; LETTER; STOMACH MUCOSA INJURY;

CELIAC DISEASE; HUMANS;

EID: 84858747344     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2011.12.008     Document Type: Letter

References (3)

1. Non-dietary therapeutic clinical trials in coeliac disease. Crespo L, Castillejo G, Cano A, León F. Eur J Intern Med 23 (1) (2012) 9-14.
2. ALV003, a novel glutenase, attenuates gluten-induced small intestinal mucosal injury in coeliac disease patients: A randomized controlled phase 2a clinical trial. Lähdeaho ML, Kaukinen K, Laurila K, Marcantonio A, Adelman D, Mäki MM. Abstract OP050B, United European Gastroenterology Week conference (UEGW 2011), Stockholm, Sweden, October 2011. Manuscript in preparation.
3. Larazotide Acetate in Patients With Active Coeliac Disease: A Randomized, Double-Blind, Placebo-Controlled Study. Murray JA, Fedorak RN, DiMarino A, Green PHR, Pluta H, Crespo L, León F, Jiang J, Wu TT. Manuscript in preparation.